Pharmacists' and pharmacy students' ability to identify drug-related problems using TIMER (Tool to Improve Medications in the Elderly via Review).

PubWeight™: 0.86‹?›

🔗 View Article (PMC 2703287)

Published in Am J Pharm Educ on May 27, 2009

Authors

Sarah Snyder Lee1, Ann K Schwemm, Jeffrey Reist, Matthew Cantrell, Michael Andreski, William R Doucette, Elizabeth A Chrischilles, Karen B Farris

Author Affiliations

1: Kansas University Medical Center, KS, USA.

Articles cited by this

Adverse drug events in ambulatory care. N Engl J Med (2003) 13.38

Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA (2003) 12.94

National surveillance of emergency department visits for outpatient adverse drug events. JAMA (2006) 6.24

Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med (1997) 5.90

Medication use leading to emergency department visits for adverse drug events in older adults. Ann Intern Med (2007) 5.39

Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med (1991) 5.30

A method for assessing drug therapy appropriateness. J Clin Epidemiol (1992) 4.36

Inappropriate prescribing for elderly Americans in a large outpatient population. Arch Intern Med (2004) 3.64

Medication Therapy Management in community pharmacy practice: core elements of an MTM service (version 1.0). J Am Pharm Assoc (2003) (2005) 3.43

The quality of pharmacologic care for vulnerable older patients. Ann Intern Med (2004) 3.34

Drug-related hospital admissions: a review of Australian studies published 1988-1996. Med J Aust (1998) 2.32

Effect of a training program on community pharmacists' detection of and intervention in drug-related problems. J Am Pharm Assoc (Wash) (1997) 1.72

Enhancing community pharmacy through advanced pharmacy practice experiences. Am J Pharm Educ (2006) 1.57

Pharmacy students' knowledge of the Medicare drug benefit and intention to provide Medicare medication therapy management services. Am J Pharm Educ (2007) 1.49

Suboptimal prescribing in elderly outpatients: potentially harmful drug-drug and drug-disease combinations. J Am Geriatr Soc (2005) 1.47

Medication therapy management: its relationship to patient counseling, disease management, and pharmaceutical care. J Am Pharm Assoc (2003) (2007) 1.37

Pharmaceutical care research and education project: pharmacists' interventions. J Am Pharm Assoc (Wash) (2001) 1.27

Reliability of a modified medication appropriateness index in ambulatory older persons. Ann Pharmacother (1997) 1.25

Comprehensive medication therapy management: identifying and resolving drug-related issues in a community pharmacy. Clin Ther (2005) 1.19

Inappropriate medication administration to the acutely ill elderly: a nationwide emergency department study, 1992-2000. J Am Geriatr Soc (2004) 1.15

A composite screening tool for medication reviews of outpatients: general issues with specific examples. Drugs Aging (2007) 1.07

Reliability of a modified medication appropriateness index in community pharmacies. Ann Pharmacother (2003) 0.97

Effect of age on the use of evidence-based therapies for acute myocardial infarction. Am Heart J (2004) 0.94

Drug insight: Statin use in the elderly. Nat Clin Pract Cardiovasc Med (2006) 0.92

Treatment with statins after acute myocardial infarction in patients >or=80 years: underuse despite general acceptance of drug therapy for secondary prevention. Pharmacoepidemiol Drug Saf (2006) 0.92

Medication therapy management services in North Carolina community pharmacies: current practice patterns and projected demand. J Am Pharm Assoc (2003) (2006) 0.79

Comment on medication management models and other pharmacist interventions: implications for policy and practice. Home Health Care Serv Q (2005) 0.78

Articles by these authors

Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol (2004) 7.02

Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med (2009) 5.75

Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer. JAMA (2010) 2.93

Palliative radiation therapy practice in patients with metastatic non-small-cell lung cancer: a Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) Study. J Clin Oncol (2013) 2.91

Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity? J Clin Oncol (2008) 2.62

A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med (2002) 2.49

A cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control. J Clin Hypertens (Greenwich) (2008) 2.37

Pharmacist participation in the workforce: 1990, 2000, and 2004. J Am Pharm Assoc (2003) (2006) 2.23

The aftermath of hip fracture: discharge placement, functional status change, and mortality. Am J Epidemiol (2009) 2.02

Hospital episodes and physician visits: the concordance between self-reports and medicare claims. Med Care (2007) 1.96

Pharmacists' attitudes toward worklife: results from a national survey of pharmacists. J Am Pharm Assoc (2003) (2004) 1.94

The role of primary care physicians in cancer care. J Gen Intern Med (2009) 1.87

Deterioration of blood pressure control after discontinuation of a physician-pharmacist collaborative intervention. Pharmacotherapy (2010) 1.82

Prediction of pharmacist intention to provide Medicare medication therapy management services using the theory of planned behavior. Res Social Adm Pharm (2006) 1.79

Was breast conserving surgery underutilized for early stage breast cancer? Instrumental variables evidence for stage II patients from Iowa. Health Serv Res (2003) 1.72

Use of colony-stimulating factors with chemotherapy: opportunities for cost savings and improved outcomes. J Natl Cancer Inst (2011) 1.71

Asthma and farm exposures in a cohort of rural Iowa children. Environ Health Perspect (2005) 1.71

Practice characteristics of bachelor of science and doctor of pharmacy degreed pharmacists based on the 2009 National Workforce Survey. Am J Pharm Educ (2010) 1.66

Influential characteristics of physician/pharmacist collaborative relationships. Ann Pharmacother (2004) 1.60

Community pharmacists' work activities in the United States during 2000. J Am Pharm Assoc (Wash) (2002) 1.52

Adherence to clinical practice guidelines for 7 chronic conditions in long-term-care patients who received pharmacist disease management services versus traditional drug regimen review. J Manag Care Pharm (2007) 1.52

Health effects of airborne exposures from concentrated animal feeding operations. Environ Health Perspect (2006) 1.52

Pharmacy students' knowledge of the Medicare drug benefit and intention to provide Medicare medication therapy management services. Am J Pharm Educ (2007) 1.49

Should I stay or should I go? The influence of individual and organizational factors on pharmacists' future work plans. J Am Pharm Assoc (2003) (2007) 1.47

Glycemic control and hypoglycemia in Veterans Health Administration patients converted from glyburide to glipizide. J Manag Care Pharm (2011) 1.47

Inappropriate prescribing predicts adverse drug events in older adults. Ann Pharmacother (2010) 1.46

Hospital volume-outcome relationships among medical admissions to ICUs. Chest (2005) 1.45

Exploring relationships among pharmacy service use, patronage motives, and patient satisfaction. J Am Pharm Assoc (2003) (2013) 1.41

Pharmaceutical care in community pharmacies: practice and research from around the world. Ann Pharmacother (2005) 1.41

Cost-effectiveness of tamsulosin, doxazosin, and terazosin in the treatment of benign prostatic hyperplasia. J Manag Care Pharm (2004) 1.39

Collaborative working relationships between pharmacists and physicians: an exploratory study. J Am Pharm Assoc (2003) (2004) 1.32

A modified model of pharmacists' job stress: the role of organizational, extra-role, and individual factors on work-related outcomes. Res Social Adm Pharm (2008) 1.31

Expectations about the effectiveness of radiation therapy among patients with incurable lung cancer. J Clin Oncol (2013) 1.30

Hip fracture risk among community-dwelling elderly people in the United States: a prospective study of physical, cognitive, and socioeconomic indicators. Am J Public Health (2006) 1.29

Incidence of and risk factors for community-associated Clostridium difficile infection: a nested case-control study. BMC Infect Dis (2011) 1.29

Predictors of older adults' capacity for medication management in a self-medication program: a retrospective chart review. J Aging Health (2003) 1.27

Continuity of care with a primary care physician and mortality in older adults. J Gerontol A Biol Sci Med Sci (2009) 1.27

A cluster-randomized effectiveness trial of a physician-pharmacist collaborative model to improve blood pressure control. Circ Cardiovasc Qual Outcomes (2010) 1.26

Beers criteria as a proxy for inappropriate prescribing of other medications among older adults. Ann Pharmacother (2011) 1.23

Predicting tobacco sales in community pharmacies using population demographics and pharmacy type. J Am Pharm Assoc (2003) (2006) 1.20

Pharmaceutical care in community pharmacies: practice and research in the US. Ann Pharmacother (2006) 1.20

An interpersonal continuity of care measure for Medicare Part B claims analyses. J Gerontol B Psychol Sci Soc Sci (2007) 1.19

The use of chiropractors by older adults in the United States. Chiropr Osteopat (2007) 1.19

Unintentional non-adherence and belief in medicines in older adults. Patient Educ Couns (2010) 1.19

Understanding the determinants of health for people with type 2 diabetes. Am J Public Health (2006) 1.17

Faculty perceptions of appropriate faculty behaviors in social interactions with student pharmacists. Am J Pharm Educ (2011) 1.14

Effect of dialysis center profit-status on patient survival: a comparison of risk-adjustment and instrumental variable approaches. Health Serv Res (2006) 1.14

Family physician perceptions of personal health records. Perspect Health Inf Manag (2010) 1.12

Assessing changes in third-party gross margin for a single community pharmacy. J Am Pharm Assoc (2003) (2014) 1.11

Sustained blood pressure control following discontinuation of a pharmacist intervention. J Clin Hypertens (Greenwich) (2011) 1.11

Development and initial validation of an instrument to measure physician-pharmacist collaboration from the physician perspective. Value Health (2005) 1.09

The concurrent use of anticholinergics and cholinesterase inhibitors: rare event or common practice? J Am Geriatr Soc (2004) 1.07

A new method to isolate local-area practice styles in prescription use as the basis for instrumental variables in comparative effectiveness research. Med Care (2010) 1.07

Emergency department utilization patterns among older adults. J Gerontol A Biol Sci Med Sci (2008) 1.07

Utility of a questionnaire to measure physician-pharmacist collaborative relationships. J Am Pharm Assoc (2003) (2006) 1.07

Population-based assessment of hospitalizations for neutropenia from chemotherapy in older adults with non-Hodgkin's lymphoma (United States). Cancer Causes Control (2006) 1.06

Recent hospitalization and the risk of hip fracture among older Americans. J Gerontol A Biol Sci Med Sci (2009) 1.05

Effect of clinical pharmacist intervention on medication discrepancies following hospital discharge. Int J Clin Pharm (2014) 1.03

Reduction in adverse symptoms as blood pressure becomes controlled. Pharmacotherapy (2008) 1.02

Heterogeneity and the interpretation of treatment effect estimates from risk adjustment and instrumental variable methods. Med Care (2007) 1.02

Health Utilities Index mark 3 demonstrated construct validity in a population-based sample with type 2 diabetes. J Clin Epidemiol (2006) 1.01

Expanding the scope of medical mission volunteer groups to include a research component. Global Health (2014) 1.00

Pharmacists' desired and actual times in work activities: evidence of gaps from the 2004 National Pharmacist Workforce Study. J Am Pharm Assoc (2003) (2006) 0.99

Determinants of different types of medication non-adherence in cholesterol lowering and asthma maintenance medications: a theoretical approach. Patient Educ Couns (2011) 0.98

Primary health care teams: team members' perceptions of the collaborative process. J Interprof Care (2004) 0.98

Relationship between physician knowledge of hypertension and blood pressure control. J Clin Hypertens (Greenwich) (2006) 0.98

Reliability of a modified medication appropriateness index in community pharmacies. Ann Pharmacother (2003) 0.97

Comparison of instrumental variable analysis using a new instrument with risk adjustment methods to reduce confounding by indication. Am J Epidemiol (2012) 0.96

The Iowa Continuity of Care study: Background and methods. Am J Health Syst Pharm (2008) 0.96

Smoking-cessation services in Iowa community pharmacies. Pharmacotherapy (2003) 0.96

Student pharmacist, pharmacy resident, and graduate student perceptions of social interactions with faculty members. Am J Pharm Educ (2011) 0.96

An evaluation of managing and educating patients on the risk of glucocorticoid-induced osteoporosis. Value Health (2005) 0.94

Days of prophylactic filgrastim use to reduce febrile neutropenia in patients with non-Hodgkin's lymphoma treated with chemotherapy. J Manag Care Pharm (2003) 0.94

Pharmacist-provided medication therapy management (part 1): provider perspectives in 2007. J Am Pharm Assoc (2003) (2008) 0.94

Defining emergency department episodes by severity and intensity: A 15-year study of Medicare beneficiaries. BMC Health Serv Res (2010) 0.94

Community pharmacists' work environments: evidence from the 2004 National Pharmacist Workforce Study. J Am Pharm Assoc (2003) (2006) 0.94

Community pharmacist-provided extended diabetes care. Ann Pharmacother (2009) 0.94

Use of the transtheoretical model in the medication use process. Ann Pharmacother (2005) 0.93

Outcomes following local therapy for early-stage breast cancer in non-trial populations. Breast Cancer Res Treat (2010) 0.92

Similar blood pressure values across racial and economic groups: baseline data from a group randomized clinical trial. J Clin Hypertens (Greenwich) (2013) 0.91

Using personal selling skills to promote pharmacy services. J Am Pharm Assoc (2003) (2003) 0.91

Osteoporosis risk screening for women in a community pharmacy. J Am Pharm Assoc (2003) (2007) 0.90

Identification of essential elements in the documentation of pharmacist-provided care. J Am Pharm Assoc (Wash) (2003) 0.90

Pancreatectomy predicts improved survival for pancreatic adenocarcinoma: results of an instrumental variable analysis. Ann Surg (2015) 0.90

Prior hospitalization and the risk of heart attack in older adults: a 12-year prospective study of Medicare beneficiaries. J Gerontol A Biol Sci Med Sci (2010) 0.90

Survival implications associated with variation in mastectomy rates for early-staged breast cancer. Int J Surg Oncol (2012) 0.89

Retrospective financial analysis of medication therapy management services from the pharmacy's perspective. J Am Pharm Assoc (2003) (2010) 0.89

Clock drawing test and medication complexity index as indicators of medication management capacity: a pilot study. J Am Pharm Assoc (2003) (2003) 0.88

Evaluation of dosing and clinical outcomes in patients undergoing conversion of insulin glargine to insulin detemir. Pharmacotherapy (2013) 0.88

Apples and oranges? Interpretations of risk adjustment and instrumental variable estimates of intended treatment effects using observational data. Am J Epidemiol (2011) 0.87

Organization and results of student pharmacist bone mineral density screenings in women. J Am Pharm Assoc (2003) (2011) 0.87

Pharmacist-provided medication therapy management (part 2): Payer perspectives in 2007. J Am Pharm Assoc (2003) (2008) 0.87

Does direct-to-consumer advertising affect patients' choice of pain medications? Curr Pain Headache Rep (2008) 0.87

Efficacy and safety of nighttime dosing of antihypertensives: review of the literature and design of a pragmatic clinical trial. J Clin Hypertens (Greenwich) (2013) 0.86